» Authors » Tim R Betts

Tim R Betts

Explore the profile of Tim R Betts including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 41
Citations 746
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Thibault B, Waddingham P, Badie N, Mangual J, McSpadden L, Betts T, et al.
CJC Open . 2025 Mar; 7(2):166-175. PMID: 40060211
Background: Cardiac resynchronization therapy (CRT) response relies on 2 factors: when and where to pace. These factors may be enhanced by dynamic atrioventricular delays (AVDs) (eg, SyncAV CRT, Abbott Cardiovascular,...
2.
Betts T, Calvert P, Graham L, Clesham G, Gunarathne A, Clapp B, et al.
Arrhythm Electrophysiol Rev . 2024 Mar; 13:e01. PMID: 38544812
Percutaneous left atrial appendage occlusion aims to reduce the risk of stroke in patients with AF, particularly those who are not good candidates for systemic anticoagulation. The procedure has been...
3.
Betts T, Calvert P, Graham L, Clesham G, Gunarathne A, Clapp B, et al.
Interv Cardiol . 2024 Mar; 19:e02. PMID: 38532943
Percutaneous left atrial appendage occlusion aims to reduce the risk of stroke in patients with AF, particularly those who are not good candidates for systemic anticoagulation. The procedure has been...
4.
Dasi A, Pope M, Wijesurendra R, Betts T, Sachetto R, Bueno-Orovio A, et al.
J Physiol . 2023 Jul; 601(18):4013-4032. PMID: 37475475
The best pharmacological treatment for each atrial fibrillation (AF) patient is unclear. We aim to exploit AF simulations in 800 virtual atria to identify key patient characteristics that guide the...
5.
Betts T, Grygier M, Nielsen Kudsk J, Schmitz T, Sandri M, Casu G, et al.
Europace . 2023 Feb; 25(3):914-921. PMID: 36734247
Aims: The FLXibility Post-Approval Study collected data on unselected patients implanted with a WATCHMAN FLX in a commercial clinical setting. Methods And Results: Patients were implanted with a WATCHMAN FLX...
6.
Gardner R, Quartieri F, Betts T, Afzal M, Manyam H, Badie N, et al.
J Cardiovasc Electrophysiol . 2022 Feb; 33(4):741-750. PMID: 35118767
Background: Insertable cardiac monitors (ICMs) are essential for ambulatory arrhythmia diagnosis. However, definitive diagnoses still require time-consuming, manual adjudication of electrograms (EGMs). Objective: To evaluate the clinical impact of selecting...
7.
Robertson C, Duffey O, Tang P, Fairhurst N, Monteiro C, Green P, et al.
J Cardiovasc Electrophysiol . 2021 Dec; 33(3):458-463. PMID: 34968010
Background: The rate of left ventricular (LV) lead displacement after cardiac resynchronization therapy (CRT) remains high despite improvements in lead technology. In 2017, a novel quadripolar lead with active fixation...
8.
Cowie M, Flett A, Cowburn P, Foley P, Chandrasekaran B, Loke I, et al.
ESC Heart Fail . 2021 Dec; 9(1):48-56. PMID: 34882989
Aims: The CardioMEMS HF System Post-Market Study (COAST) was designed to evaluate the safety, effectiveness, and feasibility of haemodynamic-guided heart failure (HF) management using a small sensor implanted in the...
9.
Leo M, Pope M, Briosa E Gala A, Betts T
HeartRhythm Case Rep . 2020 Sep; 6(9):660-662. PMID: 32983887
No abstract available.
10.
Knops R, Olde Nordkamp L, Delnoy P, Boersma L, Kuschyk J, El-Chami M, et al.
N Engl J Med . 2020 Aug; 383(6):526-536. PMID: 32757521
Background: The subcutaneous implantable cardioverter-defibrillator (ICD) was designed to avoid complications related to the transvenous ICD lead by using an entirely extrathoracic placement. Evidence comparing these systems has been based...